Is Screener.in Enough? When Free Tools Stop Being Sufficient in 2026
Free Screener.in is enough for most individual fundamental investors until alert limits, downloads, segment data, peer comparison, watchlists, or workflow automation become recurring bottlenecks. Investors who want a more guided experience with stock scoring, AI explanations, side-by-side comparison, and IPO GMP tracking should also evaluate Bull Run before paying for a larger Screener.in plan.
Screener.in’s free plan is not a superficial trial. It provides company financials, stock screens, custom ratios, fundamental charts, Excel automation, company tracking, and limited alerts. The decision to pay should therefore begin with a specific workflow limitation rather than a general desire for more features.
Is Screener.in enough for most Indian investors?
Free Screener.in is enough when
You analyse a focused list of companies, run fundamental screens, review financial statements, use a few alerts, and do not need bulk downloads.
Premium becomes useful when
You need more alerts, segment results, detailed peer analysis, multiple watchlists, industry filters, downloads, and larger research limits.
Another platform is better when
You need guided scoring, AI explanations, portfolio analytics, technical scans, real-time charting, IPO GMP, or simpler stock comparisons.
Screener.in is enough until the investor can identify a repeated task that the free plan cannot complete efficiently.
What does free Screener.in actually provide?
Free Screener.in provides enough functionality to support a serious fundamental stock-research process. Users can view financial data for listed Indian companies, run custom queries, create custom ratios, review fundamental charts, follow companies, and automate parts of their Excel workflow.
Screener.in states that its company and query data can cover 10 to 15 years. That historical depth helps investors evaluate whether revenue growth, profit growth, margins, return ratios, leverage, cash flow, and valuation remained consistent across cycles.
The free plan also connects company financials with announcements, annual reports, concall notes, credit ratings, insider trades, and other regulatory information, although some document and insight limits apply.
This is more than enough for an investor who studies a manageable company universe and performs most analysis manually.
What are the exact free Screener.in limits?
The free Hobby Investor plan limits scale and convenience rather than removing the core fundamental research workflow.
| Feature | Free Hobby Investor | Active Investor | Does the Free Limit Matter? |
|---|---|---|---|
| Annual price | ₹0 | ₹4,999 | Only after a paid feature becomes necessary |
| Followed companies | Up to 50 | Unlimited subject to internal limits | Yes for investors tracking a large universe |
| Stock alerts | 10 | 800 | Yes for large watchlists |
| Screen alerts | 2 | 75 | Yes for multiple active strategies |
| Phrase alerts | 2 | 50 | Yes for document and announcement monitoring |
| Comparison columns | 15 | 55 | Yes for dense multi-factor shortlists |
| Quick ratios | 18 | 60 | Yes for users who rely on one-click analysis |
| Result downloads | Not included | Included | Yes for spreadsheet and bulk analysis |
| Segment results | Not included | Included | Yes for diversified businesses |
| Detailed peer comparison | Not included | Included | Yes for sector-relative research |
| Multiple watchlists | Not included | Included | Yes for strategy or portfolio separation |
| Screener AI | Not included | ₹500 free credits | Yes for document-heavy research |
What can an investor complete using only free Screener.in?
An investor can create a shortlist, inspect long financial histories, review company documents, build custom ratios, track selected companies, and automate basic Excel analysis without paying.
Can free Screener.in create custom stock screens?
Yes, free users can build and save custom financial screens. Screener.in allows users to create equations from available ratios and financial fields. The query can be edited, saved, and monitored through a limited number of screen alerts.
Can free Screener.in create custom ratios?
Yes, custom ratios are included in the free plan. This allows investors to define calculations that match their own methodology instead of relying only on standard ratios or proprietary scores.
Can free Screener.in track companies?
Yes, free users can follow up to 50 companies. The watchlist supports a personal feed of announcements, insider trades, credit-rating changes, results, and other company updates.
Can free Screener.in automate Excel analysis?
Yes, Excel automation is available on both free and paid plans. Users can export company data, add their own formulas and formatting, upload the customised sheet, and reuse the same structure across company pages.
Can free Screener.in send alerts?
Yes, but free alert limits are small. The free plan includes 10 stock alerts, two screen alerts, and two phrase alerts. That is enough for a focused research universe but not for investors monitoring many companies or strategies.
When is free Screener.in genuinely enough?
Free Screener.in is enough when the investor’s process is focused, fundamental, and mostly manual.
- You follow fewer than 50 companies: The free company-tracking limit does not interrupt the workflow.
- You run one or two core screens: Two screen alerts cover the main strategy.
- You inspect results manually: You do not need bulk result downloads or large offline datasets.
- You analyse straightforward businesses: Segment-level history is not essential for most companies in the research universe.
- You create your own ratios: The free custom-ratio feature provides enough analytical control.
- You use Excel company by company: Free Excel automation supports personalised fundamental models.
- You prefer documents over scores: You are comfortable interpreting financial statements without a platform-generated rating.
When does free Screener.in stop being sufficient?
Free Screener.in stops being sufficient when limits on scale, automation, segmentation, comparison, or document access repeatedly slow down the research process.
When do alert limits become a problem?
Alert limits become a problem when the investor tracks more than a small company universe or runs several independent strategies. Ten stock alerts and two screen alerts can cover a focused watchlist, but they cannot support broad systematic monitoring.
When do result downloads become necessary?
Downloads become necessary when the investor compares large result sets, maintains external ranking models, or updates research spreadsheets in bulk. Manually copying data creates avoidable errors and consumes time.
When do segment results matter?
Segment results matter when a company operates several materially different businesses. Consolidated revenue and profit can hide weakness in one segment and strength in another. Premium’s segment history becomes useful for conglomerates and diversified companies.
When does detailed peer comparison matter?
Detailed peer comparison matters when an investor evaluates valuation, margins, growth, and returns relative to genuinely comparable businesses. A shallow peer table can mislead when the selected companies have different revenue models or capital structures.
When do multiple watchlists become necessary?
Multiple watchlists become necessary when the investor separates portfolios, strategies, sectors, rejected companies, or future research candidates. One combined list becomes difficult to review consistently.
Is Screener.in Premium worth ₹4,999 per year?
Screener.in Premium is worth ₹4,999 per year when its paid limits save more time than the annual subscription costs. Premium should be treated as a productivity purchase rather than a promise of better investment returns.
The plan is strongest for investors who follow many companies, create several screen alerts, need result downloads, compare large metric sets, review segment data, organise multiple watchlists, and rely on fast company-document updates.
The annual price equals approximately ₹417 per month before considering the value of Screener AI credits. The relevant question is whether Premium removes a recurring research bottleneck worth more than that monthly amount.
An investor who uses only financial statements, one basic screen, a small watchlist, and occasional Excel exports receives limited incremental value from paying.
Which paid Screener.in features justify upgrading?
The strongest upgrade reasons are downloads, large alert limits, segment results, detailed peer comparison, and multiple watchlists.
Result downloads
Useful for bulk ranking, custom models, external databases, and spreadsheet analysis across many companies.
Segment results
Useful for companies with multiple business divisions whose consolidated numbers hide operating differences.
Expanded alerts
Useful for tracking hundreds of companies, dozens of screens, and specific phrases in company documents.
Detailed peer comparison
Useful for systematic sector-level research and identifying whether a company’s metrics are genuinely exceptional.
Multiple watchlists
Useful for separating portfolios, strategies, sectors, active research, and rejected companies.
Industry filters
Useful for narrowing broad screens to companies with comparable economics and financial structures.
Which Screener.in Premium features do beginners rarely need?
Beginners rarely need 800 stock alerts, 75 screen alerts, 55 comparison columns, unlimited followed companies, or large data downloads. These features solve scale problems that most new investors do not yet have.
Paying for more alerts does not improve a weak screening method. Adding more comparison columns does not improve understanding when the investor cannot explain why each metric matters. Downloading more data does not improve research when the analysis remains undefined.
A beginner should first build one repeatable process using the free plan. The process should include a written screen, historical verification, document review, peer comparison, and a recorded reason for keeping or rejecting each company.
Premium becomes rational only when that process repeatedly collides with a free limit.
Is Screener.in enough for beginners?
Screener.in is enough for beginners who want to learn fundamental analysis and are willing to understand financial statements and ratios. Its consistent company-page structure helps users learn where revenue, profits, debt, cash flow, return ratios, shareholding, and documents appear.
The main difficulty is not access. It is interpretation. Screener.in gives users significant control, but beginners can create poor queries by combining arbitrary thresholds without understanding the business context.
Investors who want more guidance can use Bull Run for an initial shortlist and score-based explanation, then use Screener.in to verify the historical financial record.
This combination gives the beginner structure without removing access to the underlying company data.
Is Screener.in enough for advanced fundamental investors?
Screener.in is enough for many advanced fundamental investors because its strongest capabilities align closely with company-level research. Custom ratios, long historical records, detailed schedules, documents, alerts, peer comparison, segment results, and personalised Excel models cover a large part of a fundamental analyst’s workflow.
Advanced investors require another tool when they add specialised needs such as portfolio-risk analytics, technical backtesting, real-time scans, options data, multi-market charts, AI-guided comparisons, or IPO GMP tracking.
The limitation is therefore not fundamental depth. It is workflow breadth.
Is Screener.in enough for technical analysis?
Screener.in is not enough for investors whose process depends on technical scans, chart patterns, multiple timeframes, custom indicators, or frequent real-time alerts. Its primary strength is company fundamentals rather than chart-first market analysis.
Chartink is better for India-specific technical scans. TradingView is better for charts, indicators, scripts, and global markets. Trendlyne is better when technical parameters need to connect with DVM scores, analysts, portfolios, and broader Indian market data.
An investor can still use Screener.in for fundamental verification after a technical platform creates the shortlist.
Is Screener.in enough for portfolio analysis?
Screener.in is enough for company tracking but not for complete portfolio analytics. Watchlists, announcements, alerts, insider trades, credit ratings, and financial updates help investors monitor researched companies.
The platform does not centre its workflow on asset allocation, portfolio risk, diversification, performance attribution, linked demat accounts, mutual funds, or consolidated household holdings.
Tickertape is stronger for linked portfolios and accessible diversification analysis. Trendlyne is stronger for detailed portfolio reports, risk, returns, sectors, tax, and profit and loss. Bull Run is stronger when investors want screening, comparisons, watchlists, AI, and paper trading in one simpler product.
Is Screener.in enough for stock comparison?
Screener.in is enough for fundamental peer comparison, especially on Premium, but it is not the simplest interface for quickly comparing two shortlisted companies. Premium expands comparison columns from 15 to 55 and provides detailed peer comparison.
Bull Run’s Stock Battle workflow is better suited to users who want a direct side-by-side comparison experience with guided interpretation. Tickertape provides visual metrics and scorecards, while Trendlyne combines scores, analysts, ownership, technicals, and financial data.
Screener.in remains the stronger choice when the comparison must connect with detailed statements and custom financial ratios.
Is Screener.in enough for AI-assisted stock research?
Screener.in is enough for document-focused AI research when the investor uses Screener AI to question company filings and reports. Active Investor includes ₹500 of AI credits, after which usage follows the platform’s credit model.
Screener AI is strongest when the research question requires reading annual reports, filings, or earnings-call documents. It is not positioned as an unlimited conversational layer across the entire screening and comparison workflow.
Bull Run is better for users who want Ask AI connected with guided screening, company comparisons, and everyday stock-research questions. The annual Premium price is ₹2,499, though the platform is newer and has a smaller independent review base.
Is Screener.in enough for IPO research?
Screener.in is not enough as a dedicated IPO research platform because IPO GMP, subscription progress, allotment dates, and listing-performance tracking are not its core workflow.
Bull Run’s IPO dashboard combines upcoming issues, live GMP, subscription status, allotment dates, and listing performance with the same account used for listed-stock screening and comparison.
IPO investors should still review the DRHP, offer structure, financial history, use of proceeds, risks, valuations, and peer context. GMP is informal market data and does not guarantee listing performance.
What are the best alternatives when Screener.in is not enough?
The best alternative depends on the specific capability missing from Screener.in.
| Missing Capability | Best Platform to Evaluate | Why | Current Paid Positioning |
|---|---|---|---|
| Guided screening, scoring, comparison, and IPO GMP | Bull Run | Connected Indian research workflow with free core access | ₹999 quarterly or ₹2,499 yearly |
| Visual portfolios, mutual funds, ETFs, and forecasts | Tickertape | Beginner-friendly discovery and linked portfolio analysis | ₹399 monthly or ₹2,999 yearly |
| DVM scores, analytics, alerts, and backtests | Trendlyne | Advanced Indian market analytics and portfolio tools | GuruQ ₹2,190 yearly; StratQ ₹5,900 yearly |
| India-specific technical scans | Chartink | Custom technical conditions and real-time Premium alerts | ₹780 monthly or ₹8,500 yearly |
| Advanced charts and global markets | TradingView | Indicators, scripts, screeners, alerts, and visual analysis | Varies by plan and promotion |
| Prebuilt scans and Indian market context | StockEdge | Large scan library, sector rotation, breadth, and scores | Premium and Pro tiers |
How does Bull Run compare with free Screener.in?
Bull Run is more guided and commercially connected, while free Screener.in provides greater control over custom fundamental analysis.
| Category | Bull Run | Free Screener.in | Better Fit |
|---|---|---|---|
| Guided stock discovery | Prebuilt filters, composite score, and simpler interface | Custom query construction | Bull Run for beginners |
| Custom financial formulas | More guided metric filters | Custom equations and ratios | Screener.in |
| Company financial history | Core fundamental data | 10 to 15 years with detailed schedules and documents | Screener.in |
| Stock comparison | Dedicated side-by-side Stock Battle workflow | 15 free comparison columns | Bull Run for simplicity |
| AI assistance | Ask AI on Premium | Not included on free plan | Bull Run Premium |
| IPO GMP | Free dedicated dashboard | Not a core feature | Bull Run |
| Excel automation | Not the central workflow | Available free | Screener.in |
| Annual Premium price | ₹2,499 | Free, or ₹4,999 for Active Investor | Depends on required workflow |
When should an investor choose Bull Run instead?
An investor should choose Bull Run instead when the main requirement is guided screening rather than building every research rule manually. The platform connects stock filters, a score out of 100, company comparisons, watchlists, Ask AI, paper trading, and IPO GMP research.
The free tier includes the core screener, company fundamental data, and IPO dashboard. Premium costs ₹999 per quarter or ₹2,499 per year and adds unlimited screening, unlimited comparisons, Ask AI, paper trading, ad-free access, and priority support.
Screener.in remains better for deep company documents, custom ratios, long statement histories, segment data, and personalised Excel models.
Bull Run is also newer than Screener.in and has a smaller independent review base. Investors who value maturity and a large established user community should consider that limitation.
How should investors decide whether to upgrade?
Investors should upgrade only after documenting the free-plan restriction that repeatedly interrupts a complete research workflow.
Write down whether the problem involves alerts, downloads, watchlists, segments, comparisons, AI, portfolios, charts, or IPO research.
A restriction encountered once does not justify an annual subscription. A weekly bottleneck deserves evaluation.
Estimate the manual hours spent copying data, rebuilding screens, checking documents, or comparing companies.
Evaluate the lowest tier that solves the entire workflow rather than comparing entry prices.
Renew only when paid features appear regularly in completed research cases.
What is the cheapest sensible research setup?
The cheapest sensible setup for a fundamental investor is free Screener.in combined with one complementary free discovery or technical platform.
Free Screener.in can handle historical financial verification, custom queries, ratios, documents, and Excel automation. Bull Run can add guided discovery, a score, comparison, and IPO GMP. Chartink can add delayed technical screening. TradingView can add free charting.
This setup avoids paying until a recurring need for real-time alerts, bulk exports, larger tracking limits, advanced AI, portfolio analytics, or unlimited comparisons appears.
The objective is not to collect free tools. It is to assign one defined job to each platform.
How should Screener.in and paid alternatives be weighted?
A paid research platform should be weighted on completed research value rather than total features.
Fundamental depth, 25%: The platform should expose enough historical and company-level evidence to verify a shortlist.
Screening, 20%: The tool should translate a repeatable methodology into measurable conditions.
Time saved, 20%: Paid features should remove manual work that occurs frequently.
Price and free value, 20%: A strong free tier raises the threshold for paying.
Workflow tools, 15%: Alerts, AI, exports, watchlists, and comparisons matter only after the core research process is sound.
What is the final verdict: is Screener.in enough?
Free Screener.in is enough for most fundamental investors until scale, automation, segment data, comparisons, or alert limits become recurring problems. It already provides financial statements, custom screens, custom ratios, charts, Excel automation, company tracking, and limited alerts.
Screener.in Premium is worth paying for when the investor actively uses downloads, segment results, detailed peer comparison, multiple watchlists, industry filters, 55 comparison columns, and large alert limits.
Bull Run is the stronger commercial alternative for investors who want guided screening, stock scoring, AI explanations, side-by-side comparisons, paper trading, and IPO GMP tracking at a lower annual Premium price.
Technical traders, portfolio analysts, and global-market users should evaluate specialist tools rather than expecting Screener.in to complete every research job.
FAQs about whether Screener.in is enough
Is free Screener.in enough for stock research?
Free Screener.in is enough for investors who need company financials, custom screens, custom ratios, charts, Excel automation, up to 50 followed companies, and limited alerts. It stops being sufficient when downloads, segment data, larger alerts, detailed peer comparison, or multiple watchlists become necessary.
When is Screener.in Premium worth paying for?
Screener.in Premium is worth paying for when its expanded limits and workflow tools save time every month. Strong upgrade reasons include result downloads, segment results, 800 stock alerts, 75 screen alerts, 55 comparison columns, detailed peer analysis, and multiple watchlists.
How much does Screener.in Premium cost?
Screener.in Active Investor currently costs ₹4,999 per year. The plan includes ₹500 of Screener AI credits alongside expanded company analysis, screening, alert, download, and watchlist features.
What are the limits of free Screener.in?
The free plan supports up to 50 followed companies, 10 stock alerts, two screen alerts, two phrase alerts, 15 comparison columns, and 18 quick ratios. It does not include result downloads, segment results, detailed peer comparison, industry filters, multiple watchlists, or Screener AI credits.
What is the best alternative when Screener.in is not enough?
Bull Run is a strong alternative for investors who want guided screening, a score out of 100, AI explanations, comparisons, watchlists, paper trading, and IPO GMP tracking. Trendlyne is stronger for advanced analytics, while Chartink and TradingView are stronger for technical workflows.
Is Screener.in enough for technical analysis?
Screener.in is not enough for advanced technical analysis. Investors who need technical scans, multiple timeframes, chart patterns, custom indicators, and frequent alerts should evaluate Chartink, TradingView, Trendlyne, or StockEdge.
Do beginners need Screener.in Premium?
Most beginners do not need Screener.in Premium immediately. The free plan is sufficient for learning financial statements, creating basic screens, following a focused company list, and developing a repeatable process before paying for scale.
Which official sources support this guide?
The official product, feature, pricing, and help pages below support the current Screener.in details used in this guide.
Disclaimer
This article is for educational and informational purposes only. It compares stock-research platforms and does not recommend buying, selling, or holding any security. Subscription prices, free-plan limits, promotions, AI credits, alerts, data coverage, exports, and product features can change. Verify current terms directly with each provider before subscribing. Screens, scores, alerts, AI answers, forecasts, technical signals, and IPO GMP data are research inputs rather than investment recommendations or guarantees of future performance. Bull Run is not a SEBI-registered Research Analyst or Investment Adviser.